Blog

35 Articles

Pancreatic cancer researcher Dr. Tyler Jacks
Research
October 13, 2020 • 8 Min

An Interview with Dr. Tyler Jacks

Dr. Tyler Jacks is one of the leading pancreatic cancer researchers. Read what he has to say about KRAS, organoids, and running a lab in a pandemic.

Let's Win, Lustgarten Foundation, and AACR logos
Research
October 1, 2020 • 8 Min

AACR Virtual Special Conference on Pancreatic Cancer: Day Two Highlights

Let’s Win and the Lustgarten Foundation present highlights of Day Two of the AACR Virtual Special Conference on Pancreatic Cancer.

Let's Win, Lustgarten Foundation, and AACR logos
Research
September 30, 2020 • 7 Min

AACR Virtual Special Conference on Pancreatic Cancer: Day One Highlights

Let’s Win and the Lustgarten Foundation present highlights of Day One of the AACR Virtual Special Conference on Pancreatic Cancer.

Dr. Manish Shah
Research
April 29, 2020 • 5 Min

High-Dose Vitamin C Targeting KRAS and BRAF in Pancreatic Cancer

Dr. Manish Shah leads a clinical trial of high-dose vitamin C targeting KRAS and BRAF mutations in solid-tumor cancers, including pancreatic cancer.

Dr. Beatriz Carreno
Research
April 16, 2020 • 5 Min

Targeting Mutant KRAS with Immunotherapy

Dr. Beatriz Carreno explains how her team is targeting the KRAS mutation with a pancreatic cancer vaccine to make the immune system work against cancer.

Pancreatic Cancer Collective and Lustgarten logo and the Stand Up To Cancer logos
Research
March 23, 2020 • 6 Min

Challenge Grant Recipients Moving Forward

The Pancreatic Cancer Collective awarded four teams a second round of New Therapies Challenge Grants, to further develop new pancreatic cancer treatment.

Image of DNA reading
Symptoms
October 30, 2019 • 5 Min

Studying One Family’s Mutations May Change Pancreatic Cancer Treatment and Prevention

Dr. Sahar Nissim is studying the genetic mutations in one family predisposed to pancreatic cancer, to find new ways to combat the disease.

Researcher Rene Bernard
Research
October 17, 2019 • 3 Min

Dousing Out-of-Control KRAS Signaling in Pancreatic Cancer

Rene Bernards and his team are targeting the signaling pathway of the KRAS mutation, which occurs in almost all pancreatic cancers.

A yellow paper model of DNA helix against a dark background
Research
July 11, 2019 • 2 Min

Immunotherapy to Attack a Common Pancreatic Cancer Mutation

Researchers are testing a type of immunotherapy to attack a variant of the KRAS mutation; KRAS mutations occur in almost all pancreatic cancers.

Dr. Conan Kinsey
Research
April 8, 2019 • 6 Min

Combination Delivers a Dual Punch to Pancreatic Cell Growth

Dr. Conan Kinsey outlines a clinical trial that has moved quickly from the lab to phase I, with a dual approach to delivering pancreatic cancer treatment.

Dr. Paul Silverstein, pancreatic cancer patients
Survivor Stories
June 13, 2018 • 7 Min

Aiming to be More than a Statistic

Dr. Paul Silverstein knew that he needed genomic testing, immunotherapy, and a clinical trial in his battle with pancreatic cancer.

Dr. Elizabeth Jaffee
Research
November 20, 2017 • 4 Min

Overcoming Challenges to Vaccine Immunotherapy

Dr. Elizabeth Jaffee explains the challenges facing the scientists developing vaccine-based immunotherapy for pancreatic cancer.

DNA analysis image with red, green and light blue bars in vertical columns, all in royal blue.
Research
November 15, 2017 • 2 Min

Trying Targeted Treatments Used for Other Cancers

Researchers are trying kinase inhibitors that are effective for breast cancer, colorectal cancer, and melanoma on pancreatic cancer.

Microscope image of vitamin C crystals
Research
April 13, 2017 • 4 Min

Testing Vitamin C as a Cancer Killer

Lewis Cantley’s team is starting clinical trials of vitamin C to gain more information about its role in stopping cancer.

Microscope image of lipid bubbles
Research
December 19, 2016 • 3 Min

New Biopsy Shows Promise For Pancreatic Cancer Patients

Trovagene is developing a liquid biopsy for pancreatic cancer patients, to allow doctors to test for cancer and track treatment response.